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ARTICLE
ATP released by intestinal bacteria limits
the generation of protective IgA against
enteropathogens
Michele Proietti1,8, Lisa Perruzza1, Daniela Scribano 2,3, Giovanni Pellegrini4, Rocco D’Antuono1,
Francesco Strati 1, Marco Raffaelli1, Santiago F. Gonzalez1, Marcus Thelen1, Wolf-Dietrich Hardt5,
Emma Slack5, Mauro Nicoletti2 & Fabio Grassi 1,6,7
T cell dependent secretory IgA (SIgA) generated in the Peyer’s patches (PPs) of the small
intestine shapes a broadly diverse microbiota that is crucial for host physiology. The
mutualistic co-evolution of host and microbes led to the relative tolerance of host’s immune
system towards commensal microorganisms. The ATP-gated ionotropic P2X7 receptor limits
T follicular helper (Tfh) cells expansion and germinal center (GC) reaction in the PPs. Here
we show that transient depletion of intestinal ATP can dramatically improve high-afﬁnity IgA
response against both live and inactivated oral vaccines. Ectopic expression of Shigella ﬂexneri
periplasmic ATP-diphosphohydrolase (apyrase) abolishes ATP release by bacteria and
improves the speciﬁc IgA response against live oral vaccines. Antibody responses primed in
the absence of intestinal extracellular ATP (eATP) also provide superior protection from
enteropathogenic infection. Thus, modulation of eATP in the small intestine can affect high-
afﬁnity IgA response against gut colonizing bacteria.
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Enteric pathogens such as enteropathogenic E. coli and non-typhoidal Salmonella are a major health burden in bothhumans and animals. The rapid spread of antibiotic resis-
tance in these species highlights the need for better disease pro-
phylaxis. Protection from infection is most effective when strong
mucosal immune responses have been induced, either by prior
infection or by oral vaccination1,2. High-afﬁnity secretory IgA
(SIgA) promotes enteropathogen enchainment and aggregation to
disable and clear potentially invasive species from the intestinal
lumen3. However, balancing safety of the vaccination strain with
sufﬁcient immune stimulation has proved challenging4.
T follicular helper (Tfh) cells express high levels of the ATP-
gated P2X7 receptor, a non-selective cationic channel that opens
to form a cytolytic pore when exposed to micromolar con-
centrations of extracellular ATP (eATP). P2X7 activity therefore
controls Tfh cells abundance in Peyer’s patches (PPs): Resistance
of Tfh cells to ATP-mediated cell death by deletion of P2X7
enhances germinal center (GC) reactions5. As eATP is produced
in large quantities by the intestinal microbiota, this directly
suppresses commensal-speciﬁc IgA responses primed in the gut-
draining lymphoid tissues and affects microbiota composition6.
This study is based on the hypothesis that similar effects may
dampen immunity against enteric pathogens and oral vaccines.
We show that ATP released by intestinal bacteria permeates
the intestinal epithelium and can be found at high concentrations
in hepatic portal blood. Eliminating this eATP, via administration
of apyrase, dramatically improves the induction of speciﬁc IgA in
response to either Salmonella infection or an inactivated oral
vaccine. We could not measure any adverse effects of altered anti-
microbiota immunity secondary to oral apyrase administration,
suggesting that apyrase application is safe. Moreover, these
enhanced immune responses provide superior protection from
secondary infection.
Results
ATP released by microbiota affects Tfh cells in PPs via P2X7.
In the small intestine and portal vein of speciﬁc pathogen free
(SPF) mice, we measured micromolar concentrations of eATP
that was detected at much lower levels in germ-free (GF) mice or
in other circulatory districts (Fig. 1a, b). To address the con-
tribution of the epithelium to eATP in the small intestine, we
induced epithelial regeneration in the ileum by starvation and re-
feeding, as described7. In the presence of bacteria, the variations
in epithelial turnover by starvation and re-feeding corresponded
to undistinguishable concentrations of ileal eATP. In the absence
of bacteria, starvation did not affect the percentage of pro-
liferating cells8. However, the concentration of ileal ATP was
dramatically reduced with respect to SPF mice with comparable
amount of proliferating epithelial cells, suggesting that the great
majority of eATP measured in the ileal lumen is of bacterial
origin (Supplementary Figure 1a, b). Therefore the microbiota
generates high levels of eATP that can penetrate into the intest-
inal epithelium and draining blood. We cannot exclude that
fungi, archaea, and protozoa might also contribute to the eATP
present in the intestinal lumen. Consistent with other reports9,10;
eATP was detectable in cultures from different bacterial strains
isolated from ilea of our mouse colony (Fig. 1c) and could be
acutely exacerbated by vancomycin/ampicillin/metronidazole
(VAM) treatment (Fig. 1d, e). In vivo VAM administration
resulted in an acute signiﬁcant increase of eATP in the ileum and
portal vein blood (Fig. 1f). In wild type (WT), but not P2rx7−/−
mice, VAM administration-induced enhanced phosphatidyl-
serine (PS) exposure in Tfh cells from PPs (Fig. 1g and Supple-
mentary Figure 1c, d), suggesting bacteria-derived eATP can
modulate high-afﬁnity SIgA response. Antibiotic treatment can
be contraindicated in acute bacterial gastrointestinal infections
due to negative effects on microbiota recovery. This data further
suggest that antibiotic treatment may negatively effect the
induction of T-cell dependent intestinal immunity in these
infections.
Enhanced SIgA response by depletion of eATP. The IgA
response to E. coli is dependent on Tfh cells in PPs11 and is
signiﬁcantly enhanced in P2rx7−/− mice5, suggesting that P2X7
activity can affect the T-cell dependent SIgA response. To address
whether depleting bacteria-derived ATP could inﬂuence T cell-
dependent IgA responses via P2X7, we used a recombinant E. coli
strain (E. colipApyr) carrying an expression plasmid for Shigella
ﬂexneri's periplasmic ATP-diphosphohydrolase (apyrase) (Sup-
plementary Figure 2a–d)12,13. The supernatant of E. colipApyr
cultures showed ATP-degrading activity that was absent in E.
colipBAD28 (Fig. 2b); its fractionation resulted in the recovery of
apyrase activity within outer membrane vesicles (OMVs), sug-
gesting the enzyme was released in the extracellular space (Fig. 2a,
c). Notably, eATP14,15 was undetectable in cultures of E. colipApyr,
indicating that apyrase efﬁciently degraded ATP (Fig. 2d). To
address whether bacteria-derived ATP could selectively limit
SIgA responses in the small intestine of normally colonized ani-
mals, we administered E. colipApyr or E. colipBAD28 as control, to
SPF mice by orogastric gavage (Supplementary Figure 3b).
Administration of E. colipApyr resulted in the increase of Tfh cells
in the PPs concomitant to reduced Annexin V staining in ﬂow
cytometry, suggesting degradation of bacterial ATP reduced Tfh
cell death via P2X7 receptor (Fig. 3a). As expected, we observed a
poor SIgA response to E. coli in mice gavaged with E. colip-
BAD2816. However, anti-E. coli IgA was signiﬁcantly increased in
mice gavaged with E. colipApyr (Fig. 3b, c), despite identical
intestinal E. coli load (Supplementary Figure 3a), indicating that
abrogation of ATP release by bacteria results in the development
of high-afﬁnity IgA responses. The analysis of IgA in intestinal
washes from mice gavaged with the two E. coli transformants on
different bacterial species revealed lack of detectable reactivity
(Supplementary Figure 4a). Moreover, intestinal IgA from
untreated and immunized mice stained an analogous percentage
of commensals from WT mice (Supplementary Figure 4b),
indicating the absence of epitope-spreading to resident micro-
biota members.
To further address the role of ATP released by bacteria in
modulating the SIgA response, we monitored endoluminal ATP
after orogastric administration of E. colipBAD28 and E. colipApyr in
mice maintained with Chloramphenicol and Ampicillin (CA) (a
bactericidal mix active on endogenous ﬂora but not on CA-
resistant E. colipBAD28 and E. colipApyr) or Penicillin/Streptomy-
cin/Vancomycin (PSV) (bactericidal on both endogenous ﬂora as
well as E. coli transformants) in drinking water (Fig. 3d). Oral
gavaging with E. colipBAD28 in mice maintained in PSV as
compared to CA resulted in a signiﬁcant acute increase of
endoluminal ATP because of bacterial lysis (Fig. 3e). Notably, the
analysis of anti-E. coli IgA after multiple gavaging in this setting
showed that the increase in eATP concomitant to E. colipBAD28
gavaging in the presence of PSV correlated with reduced anti-E.
coli IgA with respect to the group treated with non-bactericidal
CA (Fig. 3f). In contrast, in mice colonized with E. colipApyr, ATP
degradation by apyrase in both treatment groups (Fig. 3e)
resulted in undistinguishable anti-E.coli IgA response (Fig. 3f).
These data further show that an increased release of ATP by
bacteria corresponds to a reduced generation of speciﬁc IgA.
Enhancement of speciﬁc SIgA by Salmonella vaccine with
apyrase. In the streptomycin mouse model of non-typhoidal
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salmonellosis17, oral infection with Salmonella enterica serovar
Typhimurium (S.Tm) leads to GALT colonization and systemic
dissemination of bacteria, as originally shown with S. enteriditis18.
To address whether apyrase expression in live-attenuated S.Tm
could increase the speciﬁc SIgA response and confer enhanced
protection from infection by a virulent strain, we generated an
attenuated S.Tm strain (ATCC 53648) carrying either pBAD28
(S.TmpBAD28) or apyrase-bearing pHND10 (S.TmpApyr) (Sup-
plementary Table 1). As observed with E. colipApyr, ATP was
undetectable in culture medium of apyrase-expressing S.TmpApyr
(Fig. 4a). Notably, Tfh and GC B cells as well as plasma cells
secreting IgA speciﬁc for Salmonella LPS were all signiﬁcantly
increased in mice immunized with S.TmpApyr (Fig. 4b, c and
Supplementary Figure 5b-d), as was the concentration of anti-
Salmonella IgA in intestinal wash (Fig. 4d).
Effective protection from Salmonella infection by S.TmpApyr.
SIgA protects the host from invasion by S.Tm or other enter-
opathogens by limiting the interaction of bacteria with the gut
epithelium19,20. In the non-typhoidal salmonellosis model, both
enchained growth and classical agglutination, requiring high-
afﬁnity IgA to cross-link dividing and colliding bacteria, are the
main protective effects3. As only non-clumped bacteria can
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approach the intestinal epithelium and invade into host tissues,
this has the effect of hugely reducing the infectious burden in the
intestine. We ﬁrst addressed whether the enhanced IgA responses
observed after vaccination with S.TmpApyr corresponded with
enhanced aggregation of Salmonella in the gut lumen. Vaccinated
mice were therefore orally infected with 1:1 mixture of GFP-
tagged and mCherry-tagged attenuated S.Tm (S.Tmatt, used to
avoid confounding inﬂammation in the control animals)21 and
cecal content was analysed at 5 h post infection by confocal
microscopy. In mice immunized with S.TmpApyr, we observed a
signiﬁcant decrease in planktonic S.Tmatt as compared to mice
immunized with S.TmpBAD28 (Fig. 4e), and fewer S. Typhimur-
ium swimming in the cecal crypts (Fig. 4f).
Correspondingly, when challenge infections were carried out
with fully virulent S. Typhimurium (S.TmWT) in S.TmpApyr
vaccinated mice, disease parameters, including histopathological
score, fecal Lipocalin 2 (LCN2) and GALT infection, were all
signiﬁcantly decreased as compared to controls or S.TmpBAD28-
vaccinated mice (Fig. 5a–c). Salmonella colonizing systemic
compartments (e.g. spleen and liver) follows a GALT-
independent route of infection (presumably via blood circula-
tion)22. Accordingly, infection with S.TmWT determines
increased permeability of the gut-vascular barrier that is reﬂected
by translocation of FITC-dextran from the intestinal lumen into
the bloodstream and liver23. Vaccinated mice were signiﬁcantly
more resistant to blood absorption of FITC-dextran administered
via orogastric route with respect to non-vaccinated animals and
immunization with S.TmpApyr conferred enhanced protection
(Fig. 5d). Moreover, S.TmWT CFUs were signiﬁcantly reduced in
the liver and spleen of these mice (Fig. 5e). These results indicate
that immunization with apyrase-expressing bacteria confers
improved protection from S.Tm systemic spreading.
Protection by S.TmpApyr depends on T-cell-dependent SIgA.
To control for effects of immunization that occur independently
of adaptive immunity, we immunized recombinase-1 deﬁcient
(Rag-1−/−) mice with S.TmpApyr or S.TmpBAD28. In Rag-1−/−
mice there was no difference in susceptibility to Salmonella
infection between non-vaccinated or either vaccinated mouse
group (Supplementary Figure 6a–e). To directly address the role
of SIgA in conferring enhanced protection by vaccination with S.
TmpApyr, we performed the same immunization-challenge pro-
tocol in mice with deletion of the JH gene. These Igh−/− mice
cannot produce recombined variable regions of Ig heavy chains
and have no detectable Ig. Analogously to Rag-1−/− mice, both
non-immunized Igh−/− mice and Igh−/− mice vaccinated with
either S.Tm transformants were equally susceptible to Salmonella
infection (Supplementary Figure 6f-j), supporting a crucial role
for SIgA in controlling the local infection and systemic spreading
of the pathogen.
We carried out experiments to mechanistically link the
abrogation of ATP to the loss of signaling via P2X7 on Tfh cells.
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We therefore immunized P2rx7−/− mice with S.TmpBAD28 or S.
TmpApyr. Whereas S.TmpApyr-induced enhanced IgA responses
in WT littermates, P2rx7−/− mice generated analogous amounts
of S.Tm-speciﬁc SIgA after immunization with live-attenuated S.
TmpBAD28 or S.TmpApyr (Supplementary Figure 7a). Accordingly,
P2rx7−/− mice were equally protected from local and systemic
infection with virulent S.Tm irrespective of the immunization
strain (Supplementary Figure 7b–d).
Improved response to inactivated oral vaccines by apyrase. We
tested the ability of apyrase to enhance the induction of IgA by
inactivated oral vaccines3,24 (Supplementary Figure 8a). We
generated these vaccines by treating pure-cultured bacteria with
1% peracetic acid (PA)—a strong oxidizing agent. Notably, no
increase of extracellular ATP was detected in the intestine of GF
mice upon oral administration of inactivated bacteria (Supple-
mentary Figure 8b). The oxidative treatment also abolished the
function of the apyrase enzyme, resulting in identical IgA priming
to a vaccine constructed from the empty-vector-carrying strain
(Fig. 6a). Correspondingly, similar protection from infection with
virulent S.Tm was observed with both vaccines (Fig. 6b, c). We
therefore administered inactivated S. Typhimurium with or
without crudely-puriﬁed apyrase extracted from E. coli that sig-
niﬁcantly decreases eATP in the small intestine (Supplementary
Figure 8c). Inclusion of apyrase in the vaccine preparation greatly
improved the IgA titer induced, similarly to that induced by
infection with the live-attenuated apyrase-expressing strain
(Figs. 4d, 6d), and generated enhanced protection from challenge
with virulent S.Tm (Fig. 6e, f). It was previously observed that the
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and S.TmpApyr. b Quantiﬁcation of Tfh and GC B cells and c representative contour plots with statistical analysis of plasma cells speciﬁc for S.Tm LPS in PPs
48 h after orogastric infection with S.TmWT in non-immunized mice (CTRL) and mice immunized with S.TmpBAD28 or S.TmpApyr. d Intestinal anti-S.Tm IgA
titer in non-immunized mice (CTRL) and mice immunized with S.TmpBAD28 or S.TmpApyr. e Representative 2D (upper panels, scale bar: 5 µm) and 3D
(lower panels, scale bar: 5 µm) images, and statistical analysis of bacterial clumping in live cecal content from mice vaccinated with S.TmpBAD28 or S.
TmpApyr, 8 h after orogastric administration of a 1:1-mix of mCherry- and GFP-tagged S.Tmatt (107 CFU). CTRL, non-vaccinated mice. f Images from two-
photon confocal microscopy of caeca and 3D rendering of crypts from E-cadherin-mCFP mice 18 h after infection with 107 CFU of GFP-tagged S.Tmatt.
Infected mice were either non-vaccinated (CTRL) or vaccinated with the indicated S.Tm transformant. Graph shows the statistics of total ﬂuorescence
inside the crypts per unit of internal area. The boxplots show median and upper and lower quartiles. The extreme lines show the highest and lowest value .
The boxplot is overlaid with the visualization of single observations. Kruskal–Wallis with Dunn’s post-test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p <
0.0001. One representative experiment out of at least three is shown
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effectiveness of inactivated vaccines was dependent on the extent
of colonization24. These results suggest that a dominant inhibi-
tory effect of the microbiota is eATP production, as antibody
titers induced by the inactivated vaccine in GF mice are similar to
those induced by the inactivated vaccine plus apyrase in colonized
animals (Fig. 6d, g). This secretory response correlates with
effective protection from subsequent infection (Fig. 6e, f, h).
Therefore, inclusion of recombinant apyrase into inactivated oral
vaccines greatly improves the responsiveness to these prepara-
tions without any major side-effects.
Discussion
The purinergic signaling system, which uses ATP and related
nucleotides as signaling molecules, plays pleiotropic roles in
regulating physiological and pathological responses in virtually all
mammalian tissues25,26. This intercellular communication
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modality emerged very early in evolution. In the endosymbiotic
relationship between α-proteobacteria and the archeon, from
which the eukaryotic cell originated, ATP released by mito-
chondria (i.e. α-proteobacteria) evolved also as a signaling
molecule to communicate mitochondrial ﬁtness27. Bacteria
release ATP via mechanosensitive channels28,29. Proteobacteria,
in particular, were shown to secrete elevated amounts of ATP that
were modulated by adherence to different surfaces30. Indeed,
ATP release as well as ATP breakdown enzymatic systems
are present in all kingdoms of life26 (Supplementary Figure 2a).
The observation that ATP released by bacteria limits Tfh cells
abundance via P2X7 receptor and ensures controlled T-
dependent SIgA responses in the small intestine indicates eATP
can act as an inter-kingdom signalling molecule. This regulatory
pathway plays a crucial role in shaping a beneﬁcial gut ecosystem
for host metabolism6. On the other hand, it contributes to the
relative resistance of the intestinal adaptive immune system to
generating high-afﬁnity SIgA upon oral immunization. Over-
coming this insensitivity has typically required the use of live-
attenuated oral vaccines, which encompass signiﬁcant safety risks.
Transient subversion of bacterial ATP-mediated control of Tfh
cells by apyrase could be exploited to enhance T cell-dependent
IgA induction by inactivated oral vaccines or to limit the harmful
potential of live-attenuated oral vaccines by speciﬁcally enhancing
SIgA response and limiting intestinal inﬂammation, at the same
time eliciting more effective and protective SIgA against enter-
opathogens. Our experiments demonstrate that this strategy is
safe and generates potent protective immune responses.
Methods
Mice. Animal experiments were performed in accordance with the Swiss Federal
Veterinary Ofﬁce guidelines and authorized by the Cantonal Veterinary. C57BL/6J,
P2rx7−/− (B6.129P2-P2rx7tm1Gab/J), Rag1−/−, Jh−/−, and E-cadherin-mCFP
(B6.129P2(Cg)-Cdh1tm1Cle/J) mice were bred in the SPF facility at the Institute
for Research in Biomedicine, Bellinzona, Switzerland. C57BL/6J GF mice were
maintained in ﬂexible ﬁlm isolators at the Clean Animal Facility, University of
Bern, Switzerland. Where indicated, mice were treated with an antibiotic associa-
tion containing Metronidazole (2.5 mg), Ampicillin (2.5 mg), and Vancomycin
(1.25 mg) (VAM) in 200 μl per mouse by oral gavage. For analysis of epithelial
turnover, mice were starved for 36 h with bedding chips and drinking water. After
starvation, mice were re-fed for 24 h and then sacriﬁced for analysis. The re-feeding
period was set to begin at 8:00 in all experiments. Where indicated, mice were
pretreated for 15 day with VAM. In all experiments, up to ﬁve mice were housed
per cage in a 12-h light-12-h dark cycle.
Determination of the ileal volume. To calculate the ileal volume, the last 5 cm of
the terminal ileum were excised from 8-week-old-female mice and ﬁxed in neutral
buffered formalin (16 h at 4 °C). After ﬁxation samples were dehydrated (70%
ethanol, two changes, 1 h each; 80% ethanol, one change, 1 h; 95% ethanol, one
change, 1 h; 100% ethanol, three changes, 1.5 h each; xylene, three changes, 1.5 h
each), embedded in parafﬁn and then cut at microtome to the desired thickness
(6 μm). Ten sections spanning the 5 cm were obtained and stained with hema-
toxylin and eosin (H&E). The internal areas of sections were calculated by ImageJ
and the mean value (base) multiplied for 5 cm (height)31 (Supplementary Figure 9).
Quantiﬁcation of ATP. For quantiﬁcation of ileal ATP, intestinal content was
collected by lavage with 10 ml of intestinal wash buffer (PBS, 0.5 M EDTA, Soybean
trypsin inhibitor, PMSF), spun and ﬁltered (0.22 μm) to remove any bacteria-sized
contaminants and immediately frozen in dry ice. ATP concentration in the
intestinal washes was multiplied for the dilution factor to obtain the actual
endoluminal ATP concentration (Supplementary Figure 9). Bile and urine were
collected from gallbladder and bladder through puncture with a 34G needle. For
quantiﬁcation of ATP secreted by commensal bacteria in culture, intestinal content
was plated on BHI agar and cultured for 16 h at 37 °C. Single colonies were picked
and cultured in BHI broth or LB. To quantify the ATP production during bacterial
growth, the bacterial culture supernatant was collected at different O.D., cen-
trifuged and ﬁltered (0.22 μm). For quantiﬁcation of ATP in serum, inferior caval,
jugular and portal veins, and hearth were exposed and blood collected through
puncture with a 34G needle. Emolysed sera were discharged. The extracellular ATP
concentration was evaluated by bioluminescence assay with recombinant ﬁreﬂy
luciferase and its substrate D-luciferin according to the manufacturerʼs protocol
(Life Technologies Europe B.V.).
OMVs isolation. OMVs were isolated from 250ml of LB cultures32. E. colipBAD28
and E. colipApyr were grown to late-exponential phase (OD600 ~0.8–1.0) and
removed from culture supernatants by centrifugation. The collected supernatants
were ﬁltered (0.22 µm) and concentrated using the Vivaspin 20 concentrators,
molecular weight cutoff 50-kDa (GE Healthcare), to eliminate free apyrase (~27
kDa) from the medium. The collected concentrates were then centrifuged at
270,000×g for 3 h at 4 °C to yield crude OMVs preparations that were resuspended
in PBS and tested for apyrase activity.
Apyrase activity test. To test the apyrase activity in bacterial supernatants, OMVs
and intestinal washes, samples were incubated with 50 µM ATP for 30 min at room
temperature. ATP concentration was evaluated by a bioluminescence assay with
recombinant ﬁreﬂy luciferase and its substrate D-luciferin according to the man-
ufacturer’s protocol (Life Technologies Europe B.V.). The ATPase activity of the
samples was expressed as the percentage of non-degraded ATP.
Antibodies and ﬂow cytometry. The following mAbs were purchased from BD
Biosciences: biotin conjugated anti-CXCR5 (clone: 2G8, Cat.#: 551960, dilution
1:50), phycoerythrin (PE) conjugated anti-ICOS (clone: 7E.17G9, Cat.#: 552146,
dilution 1:200), PE conjugated anti-CD138 (clone: 281-2, Cat #:553714, dilution
1:100) and PE conjugated anti-Fas (clone: Jo2, Cat.#: 554258, dilution 1:200).
Allophycocyanin (APC) conjugated anti-B220 (clone: RA3-6B2, Cat.#: 103212,
dilution 1:200), APC-Cy7 conjugated anti-CD19 (clone: 6D5, Cat.#: 115530,
dilution 1:200), PE-Cy7 conjugated anti-CD4 (Clone: GK1.5, Cat.# 100422, dilu-
tion 1:200), Alexa Fluor488 anti CD326 (Ep-CAM) (clone: G8.8, Cat.#: 118210,
dilution 1:200) and APC conjugated streptavidin (Cat.#: 405207, dilution 1:200)
were from Biolegend. Peridinin chlorophyll protein (Percp)-eFluor710 conjugated
anti-CD3 (Clone: 17A2, Cat.#: 46-0032-80, dilution 1:200), PE conjugated anti-Ki-
67 (clone: SolA15, Cat.#: 12-5698-82, dilution 1:200) and APC-eFluor780 anti-
CD45.2 (clone: 104, Cat.#: 47-0454-82, dilution 1:200) were obtained from
eBioscience. Fluorescein labelled Peanut Agglutinin (PNA) (Cat.#: FL-10-71,
dilution 1:500) was purchased from Vectorlabs. Fluorescein Isothiocyanate (FITC)
conjugated anti-IgA (Cat.#: 1040-02, dilution 1:500) was obtained from Southern
Biotech. To quantify IgA plasma cells speciﬁc for S.Tm, we labeled S.Tm LPS
(Sigma-Aldrich) with Hydrazide-Biotin reagent (Pierce Biotechnology) according
to the manufacturer’s instructions. Cells were stained with 30 μg ml−1 biotinylated
LPS, FITC-anti-IgA, PE-anti-CD138 antibodies at 4 °C for 45 min and then with
Alexa Fluor 647 labeled streptavidin33. Annexin V staining was performed in
Biolegend Annexin V binding buffer (Cat.#: 422201) containing Annexin V APC
(dilution 1:300) at a cell density of 1 × 106 cells ml−1. Samples were washed twice in
the same buffer, acquired on LSRFortessa ﬂow cytometer (BD Biosciences) and
data analysed using FlowJo software (TreeStar, Ashland, OR) or FACS Diva soft-
ware (BD Biosciences).
Bacterial strains and growth conditions. Full length phoN2::HA fusion, encoding
periplasmic ATP-diphosphohydrolase (apyrase) of Shigella ﬂexneri, was cloned
into the polylinker site of plasmid pBAD28 (ATCC 8739387402), under the control
of the PBAD L-arabinose inducible promoter, generating plasmid pHND1012.
Bacteria transformed with pBAD28 or pHND10 were grown in LB medium sup-
plemented with L-arabinose (0.03%) and ampicillin (100 μg ml−1). For infection
experiments, S.TmWT (SL1344 wild-type clone SB300) or the respective mutants
were cultured in LB containing the appropriate antibiotics for 12 h at 37 °C, diluted
1:20 and sub-cultured for 3 h in 0.3 M NaCl supplemented LB without antibiotics.
The bacterial strains used in the study are listed in Supplementary Table 1.
Determination of speciﬁc antibody titers by ﬂow cytometry. Speciﬁc antibody
titers in mouse intestinal washes were measured by ﬂow cytometry34. Intestinal
contents were collected by lavages with 5 ml of intestinal wash buffer (PBS, 0.5 M
EDTA, Soybean trypsin inhibitor, PMSF), spun and ﬁltered (0.22 μm) to remove
any bacteria-sized contaminants. Bacterial targets were resuspended at a density of
107 bacteria ml-1. Intestinal washes were serially diluted and 25 μl of each dilution
were incubated with 25 μl of bacterial targets suspension at 4 °C for 1 h. After two
washes, bacteria were incubated for 1 h with monoclonal FITC-anti-mouse IgA and
then resuspended in 2% paraformaldehyde in PBS for acquisition on a FACSCanto
using FSC and SSC parameters in logarithmic mode. ELISA was used to determine
the total IgA concentration in an undiluted aliquot of the same intestinal wash
sample used for analysis in ﬂow cytometry. Median ﬂuorescence intensities (MFI)
were plotted against antibody concentrations for each sample and 4-parameter
logistic curves ﬁtted using Prism (Graphpad, La Jolla, CA). Titers were calculated
from these curves as the inverse of the antibody concentration giving an above-
background signal. The concentration of total antibody titer required to achieve a
given MFI (for example= 500) was calculated by re-arrangement of the ﬁtted 4-
parameter logistic equation for each samples. As this value is low where a strong
antibody response is present, the inverse of this value was plotted. Thus titers are
calculated as the inverse total antibody concentration required to achieve a given
MFI. The y-axis value chosen as “above background” necessarily varies between
experiments due to the ﬂow cytometer settings, but is constant within any one
analysis34.
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Treatment of bacterial cultures with antibiotics. Ampicillin (2.5 μg ml−1),
vancomycin (1 μg ml−1), metronidazole (1 μg ml−1) were added to intestinal bac-
terial culture when OD600 reached 0.5 value. At different times after addition of
antibiotics, bacterial cultures were spun and supernatants collected in a sterile tube.
ATP concentration was evaluated by bioluminescence assay in ﬁltered supernatants
(see above).
Production of peracetic acid killed vaccines. To produce PA killed vaccines,
bacteria grown for 16 h to late stationary phase were collected by centrifugation
and resuspended at a density of 109–1010 ml−1 in sterile PBS. Peracetic acid
(Sigma-Aldrich) was added to a ﬁnal concentration of 1% and after vigorous
mixing, the suspension was incubated for 60 min at room temperature. After
extensive washing, the ﬁnal pellet was resuspended at a concentration of 1011
particles ml−1 in sterile PBS24. Each batch of vaccine was tested before use in order
to conﬁrm absence of live bacteria.
Preparation of periplasmic extract. E. colipBAD28 and E. colipApyr were grown as
described above and collected by centrifugation. After washing, bacteria were
resuspended (1010 CFUml−1) in PBS with 30 mM Tris-HCl (pH 8.0), 4 mM
EDTA, 1 mM PMSF, 20% sucrose and 0.5 mgml−1 lysozyme and incubated 2 min
at 30 °C. MgCl2 (10 mM ﬁnal) was added to the bacterial solution and incubation
was continued for 1 h at 30 °C. At the end of the incubation period bacterial
suspensions were centrifuged at 11,000×g for 10 min at 4 °C and supernatants were
stored (periplasmic extract).
Oral vaccination protocols. For vaccination with E. coli transformants, E. colip-
BAD28 and E. colipApyr were collected by centrifugation, washed in sterile PBS and
1010 CFUs administered to mice by orogastric gavage. The procedure was repeated
every 3 days for 3 weeks and mice were sacriﬁced at day 22 or 28 (Supplementary
Figure 3b). For vaccination with S.Tm transformants, S.TmpBAD28 and S.TmpApyr
were collected by centrifugation, washed in sterile PBS and 5 × 109 CFUs admi-
nistered to mice by orogastric gavage. The procedure was repeated every 3 days for
three times (Supplementary Figure 5b). The pBAD promoter is constantly active in
the gut lumen (E.S. and W.D.H., unpublished observations), however, to ensure
optimal apyrase expression by administered S.Tm transformants, mice were
maintained with 0.3% arabinose in drinking water. On day 28, mice were used for
infection experiments. For oral vaccination with PA killed S.TmpBAD28 and S.
TmpApyr, mice received 1010 particles of the respective transformants in PBS every
3 days for three times. When periplasmic extracts from E. colipBAD28 (mock
extract) or E. colipApyr (APY extract) were used, 100 μl of the extract was orally
gavaged every 12 h starting three days before the ﬁrst day of immunization until
day 10. On day 28, mice were used for infection experiments (Supplementary
Figure 8a).
Challenge infections with S. Typhimurium. Mice were pretreated with 1 g kg−1
streptomycin sulfate in sterile PBS by gavage. Twenty-four hours later, S.Tmwt (108
CFUs 0.1 ml−1 PBS) were gavaged into the stomach. For determination of total
bacterial loads, homogenates of PPs, mLN, spleen and liver collected at 24 and 48 h
after infection, were plated on MacConkey agar plates containing 50 μg ml−1
streptomycin.
Live confocal microscopy of cecal content. Vaccinated or control mice were
pretreated with 0.8 g kg−1 ampicillin sodium salt in sterile PBS by gavage. Twenty-
four hours later, mice received 107 CFUs of a 1:1 mix of mCherry-(pFPV25.1) and
GFP-(pM965) expressing avirulent S.Tm. For imaging, cecum content was gently
diluted to 1:10 w/v in sterile PBS containing 6 μg ml−1 chloramphenicol, avoiding
heavy mixing3. The suspension (200 μl) was transferred to 35 mm dish, 14 mm
glass diameter, poly-D-lysine coated Petri dish (MatTek Corporation) and imaged
using a Leica TCS SP5 confocal microscope with a ×100/1.44 NA oil immersion
objective (HCX PL APO CD ×100/1.44 oil). Individual bacteria were visually
scored as planktonic, whereas aggregates of equal or more than three bacteria were
scored as clumps.
Multiphoton microscopy and analysis. Vaccinated or control E-cadherin-mCFP
mice were pretreated with 0.8 g kg−1 ampicillin sodium salt in sterile PBS by
gavage. After 24 h, mice received 107 CFUs of S.Tmatt expressing GFP con-
stitutively. After 18 h, the infected animals were sacriﬁced and the whole-ceca
collected for 2-photon analysis. Deep tissue imaging was performed on a custo-
mized two-photon platform (TrimScope, LaVision BioTec)35. The objective used
was a Nikon Apo LWD ×25/1.10W IR Corrected. The ﬂuorescence signal has been
separated using a custom conﬁguration of detecting PMTs equipped with a set of
dichroic mirror and selective bandpass ﬁlters for the Blue, Green, and Red channels
(respectively detecting the ﬂuorescence in the range of 450 nm–495 nm, 500
nm–550 nm, 600 nm–635 nm). 3D reconstructions of the whole crypts shown in
Fig. 4f and Supplementary Figure 10 were performed by acquiring a z-stack with z-
step between slices of 3 μm, for a total depth of 120 μm. Images were analysed using
FIJI software36 with a custom-developed macro to automate image processing: the
internal area of crypts was segmented by applying a threshold on the intensity of
the red autoﬂuorescence (intensity above I= 1500 a.u.). Within the identiﬁed ROI
(in the red channel) the green particles above the threshold (intensity above I=
5000 a.u. in the green channel) were detected and total ﬂuorescence was measured
by summing the single particles ﬂuorescence intensity along the entire z-stack. The
obtained total intensity was normalized by the total internal area of the crypts
(obtained by summing up the single slice areas found in the red channel). 3D
renderings shown in Fig. 4f and Supplementary Figure 10 were made with Clear
Volume plugin of FIJI software37.
Histological evaluation of Salmonella-induced typhlitis. Ceca from all animals
were examined at necropsy, ﬁxed in 10% neutral buffered formalin for at least 48 h
prior to embedding in parafﬁn and stained with H&E. Pathological scores were
determined in a blinded manner using a scoring scheme, which takes into con-
sideration the severity of submucosal edema (scores 0–3), neutrophilic inﬁltration
into the lamina propria (scores 0–4), loss of goblet cells (scores 0–3), and epithelial
damage (scores 0–3)17,38.
Phylogenetic tree of apyrases. Protein sequences were retrieved from GenBank
by searching for the terms “apyrase” and “ectonucleoside triphosphate dipho-
sphohydrolase”. Putative and partial sequences were excluded from the analysis.
Protein sequences were aligned using MUSCLE39. The phylogenetic trees were
inferred by using FastTree240.
Statistical analysis. Where two groups of data were compared, analysis was
carried out using two-tailed Mann–Whitney U-tests. Where more than two groups
were compared, data were analyzed by Kruskal–Wallis test with Dunns post-test to
account for multiple testing. Statistical tests were performed using GraphPad Prism
7.02 for Windows (http://www.graphpad.com).
Reporting Summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this Article.
Data availability
The authors declare that the main data supporting the ﬁndings of this study are
available within the Article and its Supplementary Information ﬁles. A Reporting
Summary for this Article is available as a Supplementary Information ﬁle. Extra
data are available at 10.5072/zenodo.254203.
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